Location: Home  
 
  News/Announcements  
 
 
1st International Symposium on
 
Molecular Imaging and Nanomedicine
 
August 20-24, 2011, Lijiang, China
 
Symposium Language: English
Sponsored by Institute of Chemistry, CAS
Supported by 973 Program
  Background
 
Nanomedicine and nanotechnology have gained significant momentum in recent years to interplay with biology and medical science, leading to the emergence of a new interdisciplinary field called and “nanomedicine”, which have widely penetrated into the fields of life science and medical science, ranging from in vitro bioassays, to in vivo imaging and diagnosis, and drug delivery. Based on the current research achievements, nanomedicine is believed to offer powerful and multifunctional tools for the bio-detection, bioimaging, targeted drug delivery and therapeutics in the near future, which may greatly change the current status of clinical diagnosis and treatment of malignant tumors.
   
  Aims
 
The aim of this symposium is to provide a platform for exchanging ideas, to share new results and achievements in the related fields, and to strengthen the existing collaborations and meanwhile promote new collaborations among all participants in the future.e.
   
  Topics
 
1. Design and fabrication of novel molecular probes and nanoprobes;
2. Applications of nanomaterials and technology in biomedical assays;
3. Molecular mechanism and clinical diagnostics of malignant tumors;
4. In vivo imaging of tumors
   
  Chairman
 
Prof. Mingyuan Gao
Institute of Chemistry, CAS
   
  Organising Committee
 
Prof. Zhifang Cai, Institute of High Energy Physics, CAS; Soochow University
Prof. Mingyuan Gao, Institute of Chemistry, CAS
Prof. Jiacong Shen, Jilin University
Prof. Guojun Zhang, Cancer hospital of Shantou University medical college
   
  Topics
 
1. Design and fabrication of novel molecular probes and nanoprobes;
2. Applications of nanomaterials and technology in biomedical assays;
3. Molecular mechanism and clinical diagnostics of malignant tumors;
4. In vivo imaging of tumors
   
  Important Dates
  Deadline for abstract: July 1, 2011